bioCSL has commenced distribution of Immucor’s Capture technology platform and reagents in Australia and New Zealand. Capture is antibody detection technology used in the crossmatching of blood used for transfusion.
The technology is said to work differently from the techniques commonly used in Australia, delivering high levels of specificity and potentially reducing both the need for additional testing and delays for patients awaiting a blood transfusion. The product has a high degree of sensitivity for detection of clinically significant antibodies, providing confidence and accuracy in pre‐transfusion and prenatal screening.
Phone: 1300 369 559
Biosynth carbohydrates
Within the carbohydrate product range, Biosynth offers tools for glycobiology, chemo-enzymatic...
Cayman Chemical Stem Cell Small Molecule Screening Library
The screening library contains more than 140 small molecules that are known either to induce...
Cayman Chemical Bio-Active Lipid I Screening Library (96-Well)
Cayman Chemical's Bio-Active Lipid I Screening Library consists of 13 plates and contains...
